FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114955844> ?p ?o ?g. }

• W2114955844 endingPage "178" @default.
• W2114955844 startingPage "171" @default.
• W2114955844 abstract "Rate constants for human factor Va inactivation by activated human protein C (APC) were determined in the absence and presence of Ca2+ ions, protein S and varying concentrations of phospholipid vesicles of different lipid composition. APC-catalyzed factor Va inactivation in free solution (in the presence of 2 mM Ca2+) was studied under first-order reaction conditions with respect to both APC and factor Va and was characterized by an apparent second-order rate constant of 6.1 × 105 M−1 s−1. Stimulation of APC-catalyzed factor Va inactivation by phospholipids was dependent on the concentration and composition of the phospholipid vesicles. Optimal acceleration (230-fold) of factor Va inactivation was observed with 10 μM phospholipid vesicles composed of 20 mol% dioleoylglycerophosphoserine (Ole2GroPSer) and 80 mol% dioleoylglycerophosphocholine (Ole2GroPCho). At higher vesicle concentrations and at higher molar fractions of Ole2GroPSer some inhibition of APC-catalyzed factor Va inactivation was observed. Membranes that contained anionic phospholipids other than phosphatidylserine also promoted factor Va inactivation. The ability of different anionic lipids to enhance factor Va inactivation increased in the order phosphatidylethanolamine ≤ oleic acid ≤ phosphatidic acid ≤ phosphatidylglycerol ≤ phosphatidylmethanol ≤ phosphatidylserine. APC-catalyzed factor Va inactivation in the presence of phospholipid vesicles could be saturated with respect to factor Va and the reaction obeyed Michaelis-Menten kinetics. Both the Km for factor Va and the Vmax of factor Va inactivation were a function of the phospholipid concentration. The Km increased from 1 nM at 2.5 μM phospholipid (Ole2GroPSer/Ole2GroPCho 20:80, mol/mol) to 65 nM at 250 μM phospholipid. The Vmax increased from 20 mol factor Va inactivated · min−1· mol APC−1 at 2.5 μM phospholipid to 62 mol factor Va inactivated · min−1· mol APC−1 at 10 μM phospholipid and remained constant at higher phospholipid concentrations. Protein S appeared to be a rather poor stimulator of APC-catalyzed factor Va inactivation. Protein-S-dependent rate enhancements were only observed in reaction mixtures that contained negatively charged phospholipid vesicles. Independent of the concentration and the lipid composition of the vesicles, protein S caused a twofold stimulation of APC-catalyzed factor Va inactivation. This suggests that, in the human system, enhancement of APC binding to phospholipid vesicles by protein S is of minor importance. Considering that protein S is a physiologically essential antithrombotic agent it is likely that other factors or phenomena contribute to the in vivo antithrombotic action of protein S." @default.
• W2114955844 created "2016-06-24" @default.
• W2114955844 creator A5000146335 @default.
• W2114955844 creator A5005678593 @default.
• W2114955844 creator A5038108971 @default.
• W2114955844 creator A5048440499 @default.
• W2114955844 creator A5061652432 @default.
• W2114955844 creator A5066564684 @default.
• W2114955844 creator A5087919219 @default.
• W2114955844 date "1992-08-01" @default.
• W2114955844 modified "2023-09-27" @default.
• W2114955844 title "The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C" @default.
• W2114955844 cites W107781538 @default.
• W2114955844 cites W145482179 @default.
• W2114955844 cites W1482058108 @default.
• W2114955844 cites W1490126140 @default.
• W2114955844 cites W1490507833 @default.
• W2114955844 cites W1519587642 @default.
• W2114955844 cites W1525413164 @default.
• W2114955844 cites W1527081709 @default.
• W2114955844 cites W1535951790 @default.
• W2114955844 cites W1554315814 @default.
• W2114955844 cites W1563610085 @default.
• W2114955844 cites W1567449935 @default.
• W2114955844 cites W1578821085 @default.
• W2114955844 cites W1578912075 @default.
• W2114955844 cites W1580145878 @default.
• W2114955844 cites W1580349070 @default.
• W2114955844 cites W1651976025 @default.
• W2114955844 cites W1775749144 @default.
• W2114955844 cites W181622342 @default.
• W2114955844 cites W1921593426 @default.
• W2114955844 cites W1974458756 @default.
• W2114955844 cites W1983600681 @default.
• W2114955844 cites W1999591312 @default.
• W2114955844 cites W2011105427 @default.
• W2114955844 cites W2018235565 @default.
• W2114955844 cites W2023618560 @default.
• W2114955844 cites W2032279957 @default.
• W2114955844 cites W2032711004 @default.
• W2114955844 cites W2038058775 @default.
• W2114955844 cites W2039313371 @default.
• W2114955844 cites W2045458404 @default.
• W2114955844 cites W2068496108 @default.
• W2114955844 cites W2069164250 @default.
• W2114955844 cites W2072395307 @default.
• W2114955844 cites W2074044112 @default.
• W2114955844 cites W2085445739 @default.
• W2114955844 cites W2091317550 @default.
• W2114955844 cites W2100837269 @default.
• W2114955844 cites W2104431307 @default.
• W2114955844 cites W2126206535 @default.
• W2114955844 cites W2151938814 @default.
• W2114955844 cites W2170055916 @default.
• W2114955844 cites W2414783014 @default.
• W2114955844 cites W347118391 @default.
• W2114955844 cites W362194484 @default.
• W2114955844 cites W4233375127 @default.
• W2114955844 cites W4234678458 @default.
• W2114955844 cites W4235125751 @default.
• W2114955844 cites W4248895448 @default.
• W2114955844 cites W62994428 @default.
• W2114955844 cites W87735197 @default.
• W2114955844 doi "https://doi.org/10.1111/j.1432-1033.1992.tb17171.x" @default.
• W2114955844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1387359" @default.
• W2114955844 hasPublicationYear "1992" @default.
• W2114955844 type Work @default.
• W2114955844 sameAs 2114955844 @default.
• W2114955844 citedByCount "72" @default.
• W2114955844 countsByYear W21149558442012 @default.
• W2114955844 countsByYear W21149558442014 @default.
• W2114955844 countsByYear W21149558442016 @default.
• W2114955844 countsByYear W21149558442018 @default.
• W2114955844 countsByYear W21149558442020 @default.
• W2114955844 countsByYear W21149558442021 @default.
• W2114955844 countsByYear W21149558442022 @default.
• W2114955844 crossrefType "journal-article" @default.
• W2114955844 hasAuthorship W2114955844A5000146335 @default.
• W2114955844 hasAuthorship W2114955844A5005678593 @default.
• W2114955844 hasAuthorship W2114955844A5038108971 @default.
• W2114955844 hasAuthorship W2114955844A5048440499 @default.
• W2114955844 hasAuthorship W2114955844A5061652432 @default.
• W2114955844 hasAuthorship W2114955844A5066564684 @default.
• W2114955844 hasAuthorship W2114955844A5087919219 @default.
• W2114955844 hasConcept C121332964 @default.
• W2114955844 hasConcept C12554922 @default.
• W2114955844 hasConcept C130316041 @default.
• W2114955844 hasConcept C148898269 @default.
• W2114955844 hasConcept C185592680 @default.
• W2114955844 hasConcept C2776330855 @default.
• W2114955844 hasConcept C2776909261 @default.
• W2114955844 hasConcept C2778918659 @default.
• W2114955844 hasConcept C2779637612 @default.
• W2114955844 hasConcept C2781170229 @default.
• W2114955844 hasConcept C41625074 @default.
• W2114955844 hasConcept C43617362 @default.
• W2114955844 hasConcept C55493867 @default.
• W2114955844 hasConcept C62520636 @default.

• next